| 1. Ong HH, Profitt JA, Anderson VB, Spaulding TC, Wilker JC, Geyer HM.. (1982) Tricyclics with analgesic and antidepressant activity. 2. [[(Alkylamino)ethyl]thio]dibenzo[b,f]thiepins and 10,11-dihydro derivatives., 25 (10): [PMID:6128417] [10.1021/jm00352a010] |
| 2. He XS, Raymon LP, Mattson MV, Eldefrawi ME, de Costa BR.. (1993) Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologues at dopamine-uptake and phencyclidine- and sigma-binding sites., 36 (9): [PMID:8098066] [10.1021/jm00061a009] |
| 3. Glennon RA, Ablordeppey SY, Ismaiel AM, el-Ashmawy MB, Fischer JB, Howie KB.. (1994) Structural features important for sigma 1 receptor binding., 37 (8): [PMID:8164264] [10.1021/jm00034a020] |
| 4. Leland DL, Kotick MP.. (1980) Analgesic narcotic antagonists. 4. 7-Methyl-N-(cycloalkylmethyl)-3-hydroxymorphinan-6-ones and -isomorphinan-6-ones., 23 (12): [PMID:7192744] [10.1021/jm00186a025] |
| 5. Kotick MP, Leland DL, Polazzi JO, Howes JF, Bousquet AR.. (1981) Analgesic narcotic antagonists. 8. 7 alpha-Alkyl-4,5 alpha-epoxymorphinan-6-ones., 24 (12): [PMID:7310822] [10.1021/jm00144a015] |
| 6. Polazzi JO, Kotick MP, Howes JF, Bousquet AR.. (1981) Analgesic narcotic antagonists. 9. 6-Methylene-8 beta-alkyl-N-(cycloalkylmethyl)-3-hydroxy- or -methoxymorphinans., 24 (12): [PMID:6796691] [10.1021/jm00144a029] |
| 7. Quaglia W, Giannella M, Piergentili A, Pigini M, Brasili L, Di Toro R, Rossetti L, Spampinato S, Melchiorre C.. (1998) 1'-Benzyl-3,4-dihydrospiro[2H-1- benzothiopyran-2,4'-piperidine] (spipethiane), a potent and highly selective sigma1 ligand., 41 (10): [PMID:9572880] [10.1021/jm970740r] |
| 8. Ronsisvalle G, Marrazzo A, Prezzavento O, Pasquinucci L, Vittorio F, Pittalà V, Pappalardo MS, Cacciaguerra S, Spampinato S.. (1998) (+)-cis-N-ethyleneamino-N-normetazocine derivatives. Novel and selective sigma ligands with antagonist properties., 41 (10): [PMID:9572883] [10.1021/jm970333f] |
| 9. Hori M, Ban M, Imai E, Iwata N, Suzuki Y, Baba Y, Morita T, Fujimura H, Nozaki M, Niwa M.. (1985) Novel nonnarcotic analgesics with an improved therapeutic ratio. Structure-activity relationships of 8-(methylthio)- and 8-(acylthio)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines., 28 (11): [PMID:2999399] [10.1021/jm00149a020] |
| 10. Hori M, Ban M, Imai E, Iwata N, Suzuki Y, Baba Y, Morita T, Fujimura H, Nozaki M, Niwa M.. (1985) Novel nonnarcotic analgesics with an improved therapeutic ratio. Structure-activity relationships of 8-(methylthio)- and 8-(acylthio)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines., 28 (11): [PMID:2999399] [10.1021/jm00149a020] |
| 11. Waterhouse RN, Mardon K, Giles KM, Collier TL, O'Brien JC.. (1997) Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for sigma-1 receptors: in vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]pip eri dine., 40 (11): [PMID:9171875] [10.1021/jm960720+] |
| 12. Natsuka K, Nakamura H, Nishikawa Y, Negoro T, Uno H, Nishimura H.. (1987) Synthesis and structure-activity relationships of 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives having narcotic agonist and antagonist activity., 30 (10): [PMID:3656354] [10.1021/jm00393a017] |
| 13. Polazzi JO, Schut RN, Kotick MP, Howes JF, Osgood PF, Razdan RK, Villarreal JE.. (1980) Analgesic narcotic antagonists. 2. 8-Alkymorphinan-6-ones., 23 (2): [PMID:6767032] [10.1021/jm00176a013] |
| 14. Maeda DY, Williams W, Bowen WD, Coop A.. (2000) A sigma-1 receptor selective analogue of BD1008. A potential substitute for (+)-opioids in sigma receptor binding assays., 10 (1): [PMID:10636233] [10.1016/s0960-894x(99)00590-9] |
| 15. Hudkins RL, Mailman RB, DeHaven-Hudkins DL.. (1994) Novel (4-phenylpiperidinyl)- and (4-phenylpiperazinyl)alkyl-spaced esters of 1-phenylcyclopentanecarboxylic acids as potent sigma-selective compounds., 37 (13): [PMID:8027978] [10.1021/jm00039a008] |
| 16. Perregaard J, Moltzen EK, Meier E, Sánchez C.. (1995) Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(omega-aminoalkyl)-1H-indoles., 38 (11): [PMID:7783131] [10.1021/jm00011a019] |
| 17. Moltzen EK, Perregaard J, Meier E.. (1995) Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines., 38 (11): [PMID:7783132] [10.1021/jm00011a020] |
| 18. Berardi F, Loiodice F, Fracchiolla G, Colabufo NA, Perrone R, Tortorella V.. (2003) Synthesis of chiral 1-[omega-(4-chlorophenoxy)alkyl]-4-methylpiperidines and their biological evaluation at sigma1, sigma2, and sterol delta8-delta7 isomerase sites., 46 (11): [PMID:12747784] [10.1021/jm021014d] |
| 19. Hudkins RL, DeHaven-Hudkins DL. (1994) Phenytoin derivatives as potent ligands, 4 (18): [10.1016/S0960-894X(00)80068-2] |
| 20. Berardi F, Ferorelli S, Abate C, Colabufo NA, Contino M, Perrone R, Tortorella V.. (2004) 4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity., 47 (9): [PMID:15084129] [10.1021/jm031026e] |
| 21. de Costa BR, He XS, Linders JT, Dominguez C, Gu ZQ, Williams W, Bowen WD.. (1993) Synthesis and evaluation of conformationally restricted N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamines at sigma receptors. 2. Piperazines, bicyclic amines, bridged bicyclic amines, and miscellaneous compounds., 36 (16): [PMID:8360875] [10.1021/jm00068a007] |
| 22. John CS, Lim BB, Vilner BJ, Geyer BC, Bowen WD.. (1998) Substituted halogenated arylsulfonamides: a new class of sigma receptor binding tumor imaging agents., 41 (14): [PMID:9651150] [10.1021/jm9800447] |
| 23. Ronsisvalle G, Prezzavento O, Marrazzo A, Vittorio F, Massimino M, Murari G, Spampinato S.. (2002) Synthesis of (+)-cis-N-(4-isothiocyanatobenzyl)-N-normetazocine, an isothiocyanate derivative of N-benzylnormetazocine as acylant agent for the sigma(1) receptor., 45 (12): [PMID:12036376] [10.1021/jm010501a] |
| 24. Carroll FI, Abraham P, Parham K, Bai X, Zhang X, Brine GA, Mascarella SW, Martin BR, May EL, Sauss C.. (1992) Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptors., 35 (15): [PMID:1322987] [10.1021/jm00093a014] |
| 25. Soukara S, Maier CA, Predoiu U, Ehret A, Jackisch R, Wünsch B.. (2001) Methylated analogues of methyl (R)-4-(3,4-dichlorophenylacetyl)- 3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate (GR-89,696) as highly potent kappa-receptor agonists: stereoselective synthesis, opioid-receptor affinity, receptor selectivity, and functional studies., 44 (17): [PMID:11495592] [10.1021/jm0108395] |
| 26. Danso-Danquah R, Bai X, Zhang X, Mascarella SW, Williams W, Sine B, Bowen WD, Carroll FI.. (1995) Synthesis and sigma binding properties of 2'-substituted 5,9 alpha-dimethyl-6,7-benzomorphans., 38 (15): [PMID:7636860] [10.1021/jm00015a022] |
| 27. Danso-Danquah R, Bai X, Zhang X, Mascarella SW, Williams W, Sine B, Bowen WD, Carroll FI.. (1995) Synthesis and sigma binding properties of 1'- and 3'-halo- and 1',3'-dihalo-N-normetazocine analogues., 38 (15): [PMID:7636861] [10.1021/jm00015a023] |
| 28. de Costa BR, He XS, Dominguez C, Cutts J, Williams W, Bowen WD.. (1994) A new approach to the design of sigma-2-selective ligands: synthesis and evaluation of N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)ethylamine-related polyamines at sigma-1 and sigma-2 receptor subtypes., 37 (2): [PMID:8295220] [10.1021/jm00028a016] |
| 29. May EL, Aceto MD, Bowman ER, Bentley C, Martin BR, Harris LS, Medzihradsky F, Mattson MV, Jacobson AE.. (1994) Antipodal alpha-N-(methyl through decyl)-N-normetazocines (5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans): in vitro and in vivo properties., 37 (20): [PMID:7932569] [10.1021/jm00046a026] |
| 30. de Costa BR, Dominguez C, He XS, Williams W, Radesca L, Bowen W.. (1992) Synthesis and biological evaluation of conformationally restricted 2-(1-pyrrolidinyl)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methylethylenediam ines as sigma receptor ligands. 1. Pyrrolidine, piperidine, homopiperidine, and tetrahydroisoquinoline classes., 35 (23): [PMID:1447735] [10.1021/jm00101a011] |
| 31. Maier CA, Wünsch B.. (2002) Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1., 45 (2): [PMID:11784148] [10.1021/jm010992z] |
| 32. Carroll FI, Bai X, Dehghani A, Mascarella SW, Williams W, Bowen WD.. (1999) Asymmetric synthesis of 9-alkyl-2-benzyl-6,7-benzomorphans: characterization as novel sigma receptor ligands., 42 (22): [PMID:10579824] [10.1021/jm990169r] |
| 33. Huegi BS, Ebnöther AM, Rissi E, Gadient F, Hauser D, Roemer D, Hill RC, Buescher HH, Petcher TJ.. (1983) Synthesis and pharmacological studies of 4,4-disubstituted piperidines: a new class of compounds with potent analgesic properties., 26 (1): [PMID:6600791] [10.1021/jm00355a010] |
| 34. Ong HH, Profitt JA, Anderson VB, Spaulding TC, Wilker JC, Geyer HM, Kruse H.. (1980) Tricyclics with analgesic and antidepressant activity. 1. [[(Alkylamino)ethyl]thio]dibenz[b,f]oxepins and 10,11-dihydro derivatives., 23 (5): [PMID:6103962] [10.1021/jm00179a005] |
| 35. Zimmerman DM, Cantrell BE, Swartzendruber JK, Jones ND, Mendelsohn LG, Leander JD, Nickander RC.. (1988) Synthesis and analgesic properties of N-substituted trans-4a-aryldecahydroisoquinolines., 31 (3): [PMID:2831363] [10.1021/jm00398a011] |
| 36. He XS, Bowen WD, Lee KS, Williams W, Weinberger DR, de Costa BR.. (1993) Synthesis and binding characteristics of potential SPECT imaging agents for sigma-1 and sigma-2 binding sites., 36 (5): [PMID:8496936] [10.1021/jm00057a006] |
| 37. Kotick MP.. (1981) Analgesic narcotic antagonists. 6. 7 beta, 8 beta-Methano- and 7 beta, 8 beta-epoxydihydrocodeinone., 24 (6): [PMID:6114178] [10.1021/jm00138a016] |
| 38. Ong HH, Anderson VB, Wilker JC, Spaulding TC, Meyerson LR.. (1980) Synthesis and analgesic activity of some 5-(4-hydroxyphenyl)-2-azabicyclo[3.2.1]octanes., 23 (7): [PMID:6249930] [10.1021/jm00181a005] |
| 39. Glamkowski EJ, Fortunato JM, Spaulding TC, Wilker JC, Ellis DB.. (1985) 3-(1-Indolinyl)benzylamines: a new class of analgesic agents., 28 (1): [PMID:3965715] [10.1021/jm00379a014] |
| 40. Wentland MP, Albertson NF, Pierson AK.. (1980) Synthesis and pharmacology of 8-amino-3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-cis-6,11-dimethyl-2,6-methano-3-benzazocine and related compounds., 23 (1): [PMID:7359514] [10.1021/jm00175a013] |
| 41. Herlihy P, Dalzell HC, Howes JF, Razdan RK.. (1982) Novel opiates and antagonists. 5. 7-Carbethoxy-N-(cycloalkylmethyl)-3-hydroxymorphinan-6-ones and -isomorphinan-6-ones., 25 (8): [PMID:7120287] [10.1021/jm00350a020] |
| 42. Berardi F, Ferorelli S, Abate C, Pedone MP, Colabufo NA, Contino M, Perrone R.. (2005) Methyl substitution on the piperidine ring of N-[omega-(6-methoxynaphthalen-1-yl)alkyl] derivatives as a probe for selective binding and activity at the sigma(1) receptor., 48 (26): [PMID:16366605] [10.1021/jm050654o] |
| 43. Prezzavento O, Campisi A, Ronsisvalle S, Li Volti G, Marrazzo A, Bramanti V, Cannavò G, Vanella L, Cagnotto A, Mennini T, Ientile R, Ronsisvalle G.. (2007) Novel sigma receptor ligands: synthesis and biological profile., 50 (5): [PMID:17328523] [10.1021/jm0611197] |
| 44. Weigl M, Wünsch B.. (2007) Synthesis of bridged piperazines with sigma receptor affinity., 42 (10): [PMID:17420073] [10.1016/j.ejmech.2007.02.005] |
| 45. Ferorelli S, Abate C, Colabufo NA, Niso M, Inglese C, Berardi F, Perrone R.. (2007) Design and evaluation of naphthol- and carbazole-containing fluorescent sigma ligands as potential probes for receptor binding studies., 50 (19): [PMID:17713896] [10.1021/jm070373b] |
| 46. Geiger C, Zelenka C, Weigl M, Fröhlich R, Wibbeling B, Lehmkuhl K, Schepmann D, Grünert R, Bednarski PJ, Wünsch B.. (2007) Synthesis of bicyclic sigma receptor ligands with cytotoxic activity., 50 (24): [PMID:17967001] [10.1021/jm070620b] |
| 47. Baert B, Deconinck E, Van Gele M, Slodicka M, Stoppie P, Bodé S, Slegers G, Vander Heyden Y, Lambert J, Beetens J, De Spiegeleer B.. (2007) Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds., 15 (22): [PMID:17827020] [10.1016/j.bmc.2007.07.050] |
| 48. Moda TL, Montanari CA, Andricopulo AD.. (2007) Hologram QSAR model for the prediction of human oral bioavailability., 15 (24): [PMID:17870541] [10.1016/j.bmc.2007.08.060] |
| 49. Santana L, González-Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, Orallo F.. (2008) Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors., 51 (21): [PMID:18834112] [10.1021/jm800656v] |
| 50. Zampieri D, Grazia Mamolo M, Laurini E, Zanette C, Florio C, Collina S, Rossi D, Azzolina O, Vio L.. (2009) Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site., 44 (1): [PMID:18440098] [10.1016/j.ejmech.2008.03.011] |
| 51. Holl R, Schepmann D, Fröhlich R, Grünert R, Bednarski PJ, Wünsch B.. (2009) Dancing of the second aromatic residue around the 6,8-diazabicyclo[3.2.2]nonane framework: influence on sigma receptor affinity and cytotoxicity., 52 (7): [PMID:19243173] [10.1021/jm801522j] |
| 52. Cao J, Kopajtic T, Katz JL, Newman AH.. (2008) Dual DAT/sigma1 receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol., 18 (19): [PMID:18774292] [10.1016/j.bmcl.2008.08.065] |
| 53. Holl R, Schepmann D, Grünert R, Bednarski PJ, Wünsch B.. (2009) Relationships between the structure of 6-allyl-6,8-diazabicyclo[3.2.2]nonane derivatives and their sigma receptor affinity and cytotoxic activity., 17 (2): [PMID:19081725] [10.1016/j.bmc.2008.11.043] |
| 54. Berardi F, Abate C, Ferorelli S, de Robertis AF, Leopoldo M, Colabufo NA, Niso M, Perrone R.. (2008) Novel 4-(4-aryl)cyclohexyl-1-(2-pyridyl)piperazines as Delta(8)-Delta(7) sterol isomerase (emopamil binding protein) selective ligands with antiproliferative activity., 51 (23): [PMID:19053780] [10.1021/jm800965b] |
| 55. Holl R, Schepmann D, Bednarski PJ, Grünert R, Wünsch B.. (2009) Relationships between the structure of 6-substituted 6,8-diazabicyclo[3.2.2]nonan-2-ones and their sigma receptor affinity and cytotoxic activity., 17 (4): [PMID:19196515] [10.1016/j.bmc.2009.01.012] |
| 56. Karthikeyan K, Veenus Seelan T, Lalitha KG, Perumal PT.. (2009) Synthesis and antinociceptive activity of pyrazolyl isoxazolines and pyrazolyl isoxazoles., 19 (13): [PMID:19481931] [10.1016/j.bmcl.2009.05.055] |
| 57. Varma MV, Feng B, Obach RS, Troutman MD, Chupka J, Miller HR, El-Kattan A.. (2009) Physicochemical determinants of human renal clearance., 52 (15): [PMID:19445515] [10.1021/jm900403j] |
| 58. Zampieri D, Mamolo MG, Laurini E, Florio C, Zanette C, Fermeglia M, Posocco P, Paneni MS, Pricl S, Vio L.. (2009) Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma(1) receptor ligands based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives., 52 (17): [PMID:19673530] [10.1021/jm900366z] |
| 59. Berardi F, Abate C, Ferorelli S, Uricchio V, Colabufo NA, Niso M, Perrone R.. (2009) Exploring the importance of piperazine N-atoms for sigma(2) receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28)., 52 (23): [PMID:19842660] [10.1021/jm9007505] |
| 60. Jasper A, Schepmann D, Lehmkuhl K, Vela JM, Buschmann H, Holenz J, Wünsch B.. (2009) Synthesis of sigma receptor ligands with unsymmetrical spiro connection of the piperidine moiety., 44 (11): [PMID:19709783] [10.1016/j.ejmech.2009.07.017] |
| 61. Hsin LW, Chang LT, Rothman RB, Dersch CM, Fishback JA, Matsumoto RR.. (2010) Synthesis and opioid activity of enantiomeric N-substituted 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolines., 53 (3): [PMID:20055417] [10.1021/jm901503e] |
| 62. Geiger C, Zelenka C, Lehmkuhl K, Schepmann D, Englberger W, Wünsch B.. (2010) Conformationally constrained kappa receptor agonists: stereoselective synthesis and pharmacological evaluation of 6,8-diazabicyclo[3.2.2]nonane derivatives., 53 (10): [PMID:20441176] [10.1021/jm100182p] |
| 63. Banerjee A, Schepmann D, Wünsch B.. (2010) Synthesis and NMDA receptor affinity of fluorinated dioxadrol analogues., 18 (11): [PMID:20451396] [10.1016/j.bmc.2010.04.002] |
| 64. Prezzavento O, Campisi A, Parenti C, Ronsisvalle S, Aricò G, Arena E, Pistolozzi M, Scoto GM, Bertucci C, Vanella A, Ronsisvalle G.. (2010) Synthesis and resolution of cis-(+/-)-methyl (1R,2S/1S,2R)-2-[(4-hydroxy-4-phenylpiperidin-1-yl)methyl]-1-(4-methylphenyl)cyclopropanecarboxylate [(+/-)-PPCC)]: new sigma receptor ligands with neuroprotective effect., 53 (15): [PMID:20684615] [10.1021/jm100116p] |
| 65. Girisha KS, Kalluraya B, Narayana V, Padmashree.. (2010) Synthesis and pharmacological study of 1-acetyl/propyl-3-aryl-5-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-pyrazoline., 45 (10): [PMID:20702008] [10.1016/j.ejmech.2010.07.032] |
| 66. Obach RS, Lombardo F, Waters NJ.. (2008) Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds., 36 (7): [PMID:18426954] [10.1124/dmd.108.020479] |
| 67. Maestrup EG, Wiese C, Schepmann D, Brust P, Wünsch B.. (2011) Synthesis, pharmacological activity and structure affinity relationships of spirocyclic σ(1) receptor ligands with a (2-fluoroethyl) residue in 3-position., 19 (1): [PMID:21126878] [10.1016/j.bmc.2010.11.013] |
| 68. Abate C, Niso M, Lacivita E, Mosier PD, Toscano A, Perrone R.. (2011) Analogues of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with added polar functionality and reduced lipophilicity for potential use as positron emission tomography radiotracers., 54 (4): [PMID:21229979] [10.1021/jm1013133] |
| 69. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
| 70. Rack E, Fröhlich R, Schepmann D, Wünsch B.. (2011) Design, synthesis and pharmacological evaluation of spirocyclic σ(1) receptor ligands with exocyclic amino moiety (increased distance 1)., 19 (10): [PMID:21531141] [10.1016/j.bmc.2011.04.002] |
| 71. Sunnam SK, Rack E, Schepmann D, Wünsch B.. (2011) Synthesis of 7,9-diazabicyclo[4.2.2]decanes as conformationally restricted κ receptor agonists: fine tuning of the dihedral angle of the ethylenediamine pharmacophore., 46 (6): [PMID:21481987] [10.1016/j.ejmech.2011.01.064] |
| 72. Utech T, Köhler J, Wünsch B.. (2011) Synthesis of 4-(aminoalkyl) substituted 1,3-dioxanes as potent NMDA and σ receptor antagonists., 46 (6): [PMID:21444132] [10.1016/j.ejmech.2011.02.070] |
| 73. Abraham MH, Ibrahim A, Acree WE.. (2008) Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs., 43 (3): [PMID:17544548] [10.1016/j.ejmech.2007.04.002] |
| 74. Gowda J, Khader AM, Kalluraya B, Shree P, Shabaraya AR.. (2011) Synthesis, characterization and pharmacological activity of 4-{[1-substituted aminomethyl-4-arylideneamino-5-sulfanyl-4,5-dihydro-1H-1,2,4-triazol-3-yl]methyl}-2H-1,4-benzothiazin-3(4H)-ones., 46 (9): [PMID:21724303] [10.1016/j.ejmech.2011.06.010] |
| 75. Abate C, Hornick JR, Spitzer D, Hawkins WG, Niso M, Perrone R, Berardi F.. (2011) Fluorescent derivatives of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) as a tool for uptake and cellular localization studies in pancreatic tumor cells., 54 (16): [PMID:21744858] [10.1021/jm200591t] |
| 76. Schläger T, Schepmann D, Lehmkuhl K, Holenz J, Vela JM, Buschmann H, Wünsch B.. (2011) Combination of two pharmacophoric systems: synthesis and pharmacological evaluation of spirocyclic pyranopyrazoles with high σ₁ receptor affinity., 54 (19): [PMID:21859078] [10.1021/jm200585k] |
| 77. Abate C, Ferorelli S, Contino M, Marottoli R, Colabufo NA, Perrone R, Berardi F.. (2011) Arylamides hybrids of two high-affinity σ2 receptor ligands as tools for the development of PET radiotracers., 46 (9): [PMID:21684636] [10.1016/j.ejmech.2011.05.057] |
| 78. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
| 79. Ferorelli S, Abate C, Pedone MP, Colabufo NA, Contino M, Perrone R, Berardi F.. (2011) Synthesis and binding assays of novel 3,3-dimethylpiperidine derivatives with various lipophilicities as σ₁ receptor ligands., 19 (24): [PMID:22075234] [10.1016/j.bmc.2011.10.023] |
| 80. Maisonial A, Grosse Maestrup E, Wiese C, Hiller A, Schepmann D, Fischer S, Deuther-Conrad W, Steinbach J, Brust P, Wünsch B.. (2012) Synthesis, radiofluorination and pharmacological evaluation of a fluoromethyl spirocyclic PET tracer for central σ1 receptors and comparison with fluoroalkyl homologs., 20 (1): [PMID:22136765] [10.1016/j.bmc.2011.11.002] |
| 81. Chidananda N, Poojary B, Sumangala V, Kumari NS, Shetty P, Arulmoli T.. (2012) Facile synthesis, characterization and pharmacological activities of 3,6-disubstituted 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles and 5,6-dihydro-3,6-disubstituted-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles., 51 [PMID:22405287] [10.1016/j.ejmech.2012.02.030] |
| 82. Jasper A, Schepmann D, Lehmkuhl K, Vela JM, Buschmann H, Holenz J, Wünsch B.. (2012) Microwave assisted synthesis of spirocyclic pyrrolidines -σ1 receptor ligands with modified benzene-N-distance., 53 [PMID:22578786] [10.1016/j.ejmech.2012.04.018] |
| 83. Nithinchandra, Kalluraya B, Aamir S, Shabaraya AR.. (2012) Regioselective reaction: synthesis, characterization and pharmacological activity of some new Mannich and Schiff bases containing sydnone., 54 [PMID:22795833] [10.1016/j.ejmech.2012.06.011] |
| 84. Oberdorf C, Schepmann D, Vela JM, Buschmann H, Holenz J, Wünsch B.. (2012) Thiophene bioisosteres of spirocyclic σ receptor ligands: relationships between substitution pattern and σ receptor affinity., 55 (11): [PMID:22515405] [10.1021/jm300302p] |
| 85. Kozaka T, Uno I, Kitamura Y, Miwa D, Ogawa K, Shiba K.. (2012) Syntheses and in vitro evaluation of decalinvesamicol analogues as potential imaging probes for vesicular acetylcholine transporter (VAChT)., 20 (16): [PMID:22831799] [10.1016/j.bmc.2012.06.040] |
| 86. Köhler J, Bergander K, Fabian J, Schepmann D, Wünsch B.. (2012) Enantiomerically pure 1,3-dioxanes as highly selective NMDA and σ₁ receptor ligands., 55 (20): [PMID:23013229] [10.1021/jm301166m] |
| 87. Yu LF, Zhang HK, Gunosewoyo H, Kozikowski AP.. (2012) From α4β2 Nicotinic Ligands to the Discovery of σ1 Receptor Ligands: Pharmacophore Analysis and Rational Design., 3 (12): [PMID:23641311] [10.1021/ml3002715] |
| 88. Nandagokula C, Poojary B, Vittal S, Shenoy S, Shetty P, Tangavelu A. (2013) Synthesis, characterization, and biological evaluation of some N-aryl hydrazones and their 2,3-disubstituted-4-thiazolidinone derivatives, 22 (1): [10.1007/s00044-012-0028-8] |
| 89. Kankala S, Kankala RK, Gundepaka P, Thota N, Nerella S, Gangula MR, Guguloth H, Kagga M, Vadde R, Vasam CS.. (2013) Regioselective synthesis of isoxazole-mercaptobenzimidazole hybrids and their in vivo analgesic and anti-inflammatory activity studies., 23 (5): [PMID:23357631] [10.1016/j.bmcl.2012.12.101] |
| 90. Vijesh AM, Isloor AM, Shetty P, Sundershan S, Fun HK.. (2013) New pyrazole derivatives containing 1,2,4-triazoles and benzoxazoles as potent antimicrobial and analgesic agents., 62 [PMID:23385092] [10.1016/j.ejmech.2012.12.057] |
| 91. Niso M, Abate C, Ferorelli S, Cassano G, Gasparre G, Perrone R, Berardi F.. (2013) Investigation of σ receptors agonist/antagonist activity through N-(6-methoxytetralin-1-yl)- and N-(6-methoxynaphthalen-1-yl)alkyl derivatives of polymethylpiperidines., 21 (7): [PMID:23415062] [10.1016/j.bmc.2013.01.034] |
| 92. Meyer C, Neue B, Schepmann D, Yanagisawa S, Yamaguchi J, Würthwein EU, Itami K, Wünsch B.. (2013) Improvement of σ1 receptor affinity by late-stage C-H-bond arylation of spirocyclic lactones., 21 (7): [PMID:23462714] [10.1016/j.bmc.2013.01.038] |
| 93. Sadeghzadeh M, Sheibani S, Ghandi M, Daha FJ, Amanlou M, Arjmand M, Hasani Bozcheloie A.. (2013) Synthesis and receptor binding studies of novel 4,4-disubstituted arylalkyl/arylalkylsulfonyl piperazine and piperidine-based derivatives as a new class of σ1 ligands., 64 [PMID:23680866] [10.1016/j.ejmech.2013.04.013] |
| 94. Harel D, Schepmann D, Wünsch B.. (2013) New combination of pharmacophoric elements of potent σ₁ ligands: design, synthesis and σ receptor affinity of aminoethyl substituted tetrahydrobenzothiophenes., 69 [PMID:24095744] [10.1016/j.ejmech.2013.09.006] |
| 95. Abate C, Selivanova SV, Müller A, Krämer SD, Schibli R, Marottoli R, Perrone R, Berardi F, Niso M, Ametamey SM.. (2013) Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging of σ₂ receptors., 69 [PMID:24161678] [10.1016/j.ejmech.2013.09.018] |
| 96. Torres-Gómez H, Lehmkuhl K, Schepmann D, Wünsch B.. (2013) Design, synthesis and receptor affinity of novel conformationally restricted σ ligands based on the [4.3.3]propellane scaffold., 70 [PMID:24140950] [10.1016/j.ejmech.2013.09.021] |
| 97. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R.. (2004) [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]., 28 (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2] |
| 98. Holl R, Schepmann D, Wunsch B. (2012) Homologous piperazine-alcanols: chiral pool synthesis and pharmacological evaluation, 3 (6): [10.1039/C2MD20070H] |
| 99. Banerjee A, Frohlich R, Schepmann D, Wunsch B. (2010) Synthesis and NMDA receptor affinity of dexoxadrol analogues with modifications in position 4 of the piperidine ring, 1 (1): [10.1039/C0MD00017E] |
| 100. Shimokawa N, Nakamura H, Shimakawa K, Minami H, Nishimura H.. (1979) Studies on analgesic agents. 1.1a Preparation of 1,2-diphenyl-2-(4-substituted 1-piperazinyl)ethanol derivatives and structure-activity relationships., 22 (1): [PMID:106119] [10.1021/jm00187a014] |
| 101. Weber F, Brune S, Korpis K, Bednarski PJ, Laurini E, Dal Col V, Pricl S, Schepmann D, Wünsch B.. (2014) Synthesis, pharmacological evaluation, and σ1 receptor interaction analysis of hydroxyethyl substituted piperazines., 57 (7): [PMID:24617836] [10.1021/jm401707t] |
| 102. Lan Y, Chen Y, Xu X, Qiu Y, Liu S, Liu X, Liu BF, Zhang G.. (2014) Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic., 79 [PMID:24735647] [10.1016/j.ejmech.2014.04.019] |
| 103. Mach RH, Zeng C, Hawkins WG.. (2013) The σ2 receptor: a novel protein for the imaging and treatment of cancer., 56 (18): [PMID:23734634] [10.1021/jm301545c] |
| 104. Ong HH, Anderson VB, Wilker JC.. (1978) Synthesis and analgetic activity of some 5-aryl-2azabicyclo[3.2.1]octanes., 21 (8): [PMID:691001] [10.1021/jm00206a008] |
| 105. Albertson NF, McKay FC.. (1977) Synthesis of some pentazocine metabolites and related compounds., 20 (4): [PMID:850250] [10.1021/jm00214a036] |
| 106. Fisher MH, Grabowski EJ, Patchett AA, ten Broeke J.. (1977) 5,11-dimethyl-2,9-bis(phenylacetyl)-5,11-diazatetracyclo[6.2.2.0(2,7).0(4,9)]dodecane, a potent, novel analgesic., 20 (1): [PMID:13216] [10.1021/jm00211a012] |
| 107. Ong HH, Profitt JA, Spaulding TC, Wilker JC.. (1979) Synthesis and analgesic activity of some spiro[dibenz[b,f]oxepin-10,4'-piperidine] derivatives., 22 (7): [PMID:448682] [10.1021/jm00193a016] |
| 108. Abate C, Niso M, Marottoli R, Riganti C, Ghigo D, Ferorelli S, Ossato G, Perrone R, Lacivita E, Lamb DC, Berardi F.. (2014) Novel derivatives of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with improved fluorescent and σ receptors binding properties., 57 (8): [PMID:24697311] [10.1021/jm401874n] |
| 109. Bai S, Li S, Xu J, Peng X, Sai K, Chu W, Tu Z, Zeng C, Mach RH.. (2014) Synthesis and structure-activity relationship studies of conformationally flexible tetrahydroisoquinolinyl triazole carboxamide and triazole substituted benzamide analogues as σ2 receptor ligands., 57 (10): [PMID:24821398] [10.1021/jm5001453] |
| 110. Winn M, Arendsen D, Dodge P, Dren A, Dunnigan D, Hallas R, Hwang K, Kyncl J, Lee YH, Plotnikoff N, Young P, Zaugg H.. (1976) Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains., 19 (4): [PMID:817021] [10.1021/jm00226a003] |
| 111. Montzka TA, Matiskella JD.. (1977) Narcotic antagonists. Synthesis and evaluation of some subsituted 1,2,3,4,5,6-hexahydro-1,4:2,6-dimethano-3-benzazocines., 20 (3): [PMID:845878] [10.1021/jm00213a027] |
| 112. Laurini E, Harel D, Marson D, Schepmann D, Schmidt TJ, Pricl S, Wünsch B.. (2014) Identification, pharmacological evaluation and binding mode analysis of novel chromene and chromane based σ1 receptor ligands., 83 [PMID:24996139] [10.1016/j.ejmech.2014.06.054] |
| 113. Miyata K, Möller G, Schepmann D, Wünsch B.. (2014) Pyridine analogues of spirocyclic σ₁ receptor ligands., 22 (15): [PMID:24913984] [10.1016/j.bmc.2014.05.033] |
| 114. Abate C, Pati ML, Contino M, Colabufo NA, Perrone R, Niso M, Berardi F.. (2015) From mixed sigma-2 receptor/P-glycoprotein targeting agents to selective P-glycoprotein modulators: small structural changes address the mechanism of interaction at the efflux pump., 89 [PMID:25462269] [10.1016/j.ejmech.2014.10.082] |
| 115. Pati ML, Abate C, Contino M, Ferorelli S, Luisi R, Carroccia L, Niso M, Berardi F.. (2015) Deconstruction of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety to separate P-glycoprotein (P-gp) activity from σ2 receptor affinity in mixed P-gp/σ2 receptor agents., 89 [PMID:25462276] [10.1016/j.ejmech.2014.11.001] |
| 116. Xu R, Lord SA, Peterson RM, Fergason-Cantrell EA, Lever JR, Lever SZ.. (2015) Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters., 23 (1): [PMID:25468036] [10.1016/j.bmc.2014.11.007] |
| 117. Bourgeois C, Werfel E, Galla F, Lehmkuhl K, Torres-Gómez H, Schepmann D, Kögel B, Christoph T, Straßburger W, Englberger W, Soeberdt M, Hüwel S, Galla HJ, Wünsch B.. (2014) Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted κ-opioid receptor agonists., 57 (15): [PMID:25062506] [10.1021/jm500940q] |
| 118. Banerjee AG, Das N, Shengule SA, Srivastava RS, Shrivastava SK.. (2015) Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents., 101 [PMID:26117820] [10.1016/j.ejmech.2015.06.020] |
| 119. Viveka S, Dinesha, Shama P, Nagaraja GK, Ballav S, Kerkar S.. (2015) Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents., 101 [PMID:26186150] [10.1016/j.ejmech.2015.07.002] |
| 120. Bonifazi A, Del Bello F, Mammoli V, Piergentili A, Petrelli R, Cimarelli C, Pellei M, Schepmann D, Wünsch B, Barocelli E, Bertoni S, Flammini L, Amantini C, Nabissi M, Santoni G, Vistoli G, Quaglia W.. (2015) Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring., 58 (21): [PMID:26430967] [10.1021/acs.jmedchem.5b01214] |
| 121. Abate C, Riganti C, Pati ML, Ghigo D, Berardi F, Mavlyutov T, Guo LW, Ruoho A.. (2016) Development of sigma-1 (σ1) receptor fluorescent ligands as versatile tools to study σ1 receptors., 108 [PMID:26717207] [10.1016/j.ejmech.2015.12.014] |
| 122. Galla F, Bourgeois C, Lehmkuhl K, Schepmann D, Soeberdt M, Lotts T, Abels C, Stander S, Wunsch B. (2016) Effects of polar receptor agonists designed for the periphery on ATP-induced Ca2+release from keratinocytes, 7 (2): [10.1039/C5MD00414D] |
| 123. Ghandi M, Sherafat F, Sadeghzadeh M, Alirezapour B.. (2016) One-pot synthesis and sigma receptor binding studies of novel spirocyclic-2,6-diketopiperazine derivatives., 26 (11): [PMID:27090556] [10.1016/j.bmcl.2016.04.010] |
| 124. Weber F, Brune S, Börgel F, Lange C, Korpis K, Bednarski PJ, Laurini E, Fermeglia M, Pricl S, Schepmann D, Wünsch B.. (2016) Rigidity versus Flexibility: Is This an Issue in σ1 Receptor Ligand Affinity and Activity?, 59 (11): [PMID:27156565] [10.1021/acs.jmedchem.6b00585] |
| 125. Knappmann I, Schepmann D, Wünsch B.. (2016) Oxa-Pictet-Spengler reaction as key step in the synthesis of novel σ receptor ligands with 2-benzopyran structure., 24 (18): [PMID:27396684] [10.1016/j.bmc.2016.06.046] |
| 126. Zampieri D, Vio L, Fermeglia M, Pricl S, Wünsch B, Schepmann D, Romano M, Mamolo MG, Laurini E.. (2016) Computer-assisted design, synthesis, binding and cytotoxicity assessments of new 1-(4-(aryl(methyl)amino)butyl)-heterocyclic sigma 1 ligands., 121 [PMID:27366902] [10.1016/j.ejmech.2016.06.001] |
| 127. Soeberdt M, Molenveld P, Storcken RP, Bouzanne des Mazery R, Sterk GJ, Autar R, Bolster MG, Wagner C, Aerts SN, van Holst FR, Wegert A, Tangherlini G, Frehland B, Schepmann D, Metze D, Lotts T, Knie U, Lin KY, Huang TY, Lai CC, Ständer S, Wünsch B, Abels C.. (2017) Design and Synthesis of Enantiomerically Pure Decahydroquinoxalines as Potent and Selective κ-Opioid Receptor Agonists with Anti-Inflammatory Activity in Vivo., 60 (6): [PMID:28218838] [10.1021/acs.jmedchem.6b01868] |
| 128. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
| 129. Knappmann I, Lehmkuhl K, Köhler J, Schepmann D, Giera M, Bracher F, Wünsch B.. (2017) Lipase-catalyzed kinetic resolution as key step in the synthesis of enantiomerically pure σ ligands with 2-benzopyran structure., 25 (13): [PMID:28501431] [10.1016/j.bmc.2017.04.042] |
| 130. Asare-Nkansah S, Schepmann D, Wünsch B.. (2017) Synthesis of conformationally restricted 1,3-dioxanes to analyze the bioactive conformation of 1,3-dioxane-based σ1 and PCP receptor antagonists., 25 (8): [PMID:28320613] [10.1016/j.bmc.2017.03.014] |
| 131. Fanter L, Müller C, Schepmann D, Bracher F, Wünsch B.. (2017) Chiral-pool synthesis of 1,2,4-trisubstituted 1,4-diazepanes as novel σ1 receptor ligands., 25 (17): [PMID:28764962] [10.1016/j.bmc.2017.07.027] |
| 132. Torres-Gómez H, Daniliuc C, Schepmann D, Wünsch B.. (2018) Synthesis of 3-aza[4.4.3]propellanes with high σ1 receptor affinity., 26 (8): [PMID:29482951] [10.1016/j.bmc.2018.02.019] |
| 133. Porter MR, Xiao H, Wang J, Smith SB, Topczewski JJ.. (2019) 3-Amino-chromanes and Tetrahydroquinolines as Selective 5-HT2B, 5-HT7, or σ1 Receptor Ligands., 10 (10): [PMID:31620230] [10.1021/acsmedchemlett.9b00225] |
| 134. Kronenberg E, Weber F, Brune S, Schepmann D, Almansa C, Friedland K, Laurini E, Pricl S, Wünsch B.. (2019) Synthesis and Structure-Affinity Relationships of Spirocyclic Benzopyrans with Exocyclic Amino Moiety., 62 (8): [PMID:30939014] [10.1021/acs.jmedchem.9b00449] |
| 135. Iyamu ID, Lv W, Malik N, Mishra RK, Schiltz GE.. (2019) Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands., 27 (9): [PMID:30904383] [10.1016/j.bmc.2019.03.030] |
| 136. Baumeister S, Schepmann D, Wünsch B.. (2020) Thiophene bioisosteres of GluN2B selective NMDA receptor antagonists: Synthesis and pharmacological evaluation of [7]annuleno[b]thiophen-6-amines., 28 (2): [PMID:31843460] [10.1016/j.bmc.2019.115245] |
| 137. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
| 138. Díaz JL,García M,Torrens A,Caamaño AM,Enjo J,Sicre C,Lorente A,Port A,Montero A,Yeste S,Álvarez I,Martín M,Maldonado R,de laPuente B,Vidal-Torres A,Cendán CM,Vela JM,Almansa C. (2020) EST64454: a Highly Soluble σ Receptor Antagonist Clinical Candidate for Pain Management., 63 (23): [PMID:33237785] [10.1021/acs.jmedchem.0c01575] |
